Randomized Controlled Trial of Two Dosing Schedules for Human Papillomavirus Vaccination among College Age Males

BACKGROUND: Quadrivalent human papillomavirus (HPV) vaccine, for protection against sexually transmitted HPV infection, is licensed for females and males 9–26 years on a 3-dose schedule (0, 2, and 6 months; Standard schedule). Vaccine uptake has been low and catch-up vaccination of older adolescents...

Full description

Saved in:
Bibliographic Details
Main Authors: Lin, Chyongchiou Jeng, Zimmerman, Richard K, Nowalk, Mary Patricia, Huang, Hsin-Hui, Raviotta, Jonathan M.
Format: Artigo
Language:Inglês
Published: 2013
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4048919/
https://ncbi.nlm.nih.gov/pubmed/24342252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2013.11.098
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items